Phendimetrazine Tartrate
Composition
This formulation contain Phendimetrazine Tartrate pharmaceutical ingrediant.
Indications
It is indicated for the short-term treatment of obesity as part of a comprehensive weight reduction regimen, including diet and exercise.
Side effects
Common side effects include increased heart rate, palpitations, insomnia, dry mouth, dizziness.
Precautions
Use with caution in patients with cardiovascular disease, hypertension, hyperthyroidism, glaucoma.
Contraindications
Contraindicated in patients with advanced arteriosclerosis, cardiovascular disease.
Dosage and administration
As directed by healthcare provider.
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai